We are so excited to announce Dr. Willie J. McKinney, Ph.D., D.A.B.T., has joined PHILTER's Scientific and Strategic Advisory Board (SSAB). We strive to solve the major public issue of exposure to secondhand vape and smoke with our proprietary and patented filtration technology. Dr. McKinney’s expertise in vaping science and technology, and experience in the e-cigarette industry, will assist us in identifying and integrating our nanofiltration process into new commercial products that reduce harm from secondhand smoke.
Since our launch in mid-2019, PHILTER has quickly gained popularity among smokers and vapers alike. We've already raised $3 million in growth funding and secured and announced distribution partnerships across multiple channels in North America. We also earned widespread media attention, grown our social media presence, and are developing new and innovative products, thus redefining the personal filtration product category.
“I am impressed with Philter Labs’ experienced team and their filtration innovations. They are in the right place at the right time with the right technology to address secondhand smoke emissions,” Dr. Willie McKinney said. “The opportunities to create safer vaping products is vast, and that gets me excited.”
Led by our incredible Co-Founder and CTO, John Grimm, PHILTER has invented and patented ZERO-5 Technology -- a five-step, nanofiltration process that molecularly manipulates secondhand vape and smoke to reduce emissions; all encapsulated in a filter measuring at a mere 4 inches tall and ½ inch wide.
“We are proud to have Dr. McKinney join us as an advisor. His expertise in toxicology married with his experience in a rapidly evolving market, complement our mission to use technology to help protect the health of the person who chooses to vape, and of those around them,” Philter Labs Co-Founder and CEO, Christos Nicolaidis said.
The Scientific and Strategic Advisory Board provides short and long-term business counsel and advises Philter Labs, Inc. on technical and strategic initiatives to expand the company’s impact on mitigating secondhand smoke.
Dr. Willie J. McKinney: Biography
Dr. Willie J. McKinney is the Founder and CEO of McKinney Regulatory Science Advisors. In 1998 Dr. McKinney joined the Altria family of companies and held a number of academic and research roles before joining the Executive Leadership Team as Vice President of Regulatory Sciences. His team developed innovative and defensible scientific evaluation and regulatory submission strategies. His time at Altria was followed by serving as Vice President of Global Regulatory Affairs for JUUL labs in San Francisco.
Dr. McKinney served on FDA’s Tobacco Product Scientific Advisory Committee (TPSAC). Board Certified as a Toxicologist by the American Board of Toxicology in 2004, Dr. McKinney holds a Ph.D., in Environmental Toxicology from the University of North Carolina at Chapel Hill, and M.S., in Biology, from North Carolina Central University, and a B.S., in Biology from Xavier University in New Orleans.